Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center

Critical Care Medicine

Volumn 25, Issue 10, 1997, Pages 1678-1684

  Erstad, Brian L ^a   Camamo, James M ^b   Miller, Michael J ^c   Webber, Anthony M ^d   Fortune, John ^e  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^c VA Cooperative Studies Program   (United States)

^d CARL T HAYDEN VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cost; Education; Gastrointestinal hemorrhage; Prophylaxis; Ranitidine; Sucralfate

Indexed keywords

SUCRALFATE;

ARTICLE; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; DISEASE DURATION; DRUG COST; EDUCATION PROGRAM; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; STRESS ULCER; TREATMENT OUTCOME; TREATMENT PLANNING;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ANTI-ULCER AGENTS; ARIZONA; FEMALE; HISTAMINE H2 ANTAGONISTS; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INTERVENTION STUDIES; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PEPTIC ULCER; PRACTICE GUIDELINES; STRESS, PSYCHOLOGICAL; SUCRALFATE;

EID: 0030770705     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199710000-00017     Document Type: Article

References (29)

1. Fabian TC, Boucher BA, Croce MA, et al: Pneumonia and stress ulceration in severely injured patients: A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993; 128:185-192
2. Cook DJ, Reeve BK, Guyatt GH, et al: Stress ulcer prophylaxis in critically ill patients: Resolving discordant meta-analyses. JAMA 1996; 275:308-314
3. Tryba M: Stress ulcer prophylaxis and gastric alkalinization: Death of a myth? Intensive Care Med 1992; 18:1-3
4. Schuster DP: Stress ulcer prophylaxis: In whom? With what? Crit Care Med 1993; 21:4-6
5. Peura DA, Johnson CF: Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med 1985; 103:173-177
6. Knight George AB, Bihari DJ: Gastric intramural pH and stress ulcer prophylaxis in critically ill patients. Clin Intensive Care 1990; 1:249-255
7. 2-antagonists for stress ulcer prophylaxis: A meta-analysis of efficacy and pneumonia rate. Crit Care Med 1991; 19:942-949
8. Cook DJ, Laine LA, Guyatt GH, et al: Nosocomial pneumonia and the role of gastric pH: A meta-analysis. Chest 1991; 100:7-13
9. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330:377-381
10. Martin LF: Gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 331:51
11. Simons RK, Hoyt DB, Winchell RJ, et al: A risk analysis of stress ulceration after trauma. Journal of Trauma, Injury, Infection, and Critical Care 1995; 39:289-294
12. Hospital Infection Control Practices Advisory Committee: Part II: Recommendations for prevention of nosocomial pneumonia. Am J Infect Control 1994; 22:247-292
13. Roche N, Durieux P: Clinical practice guidelines: From methodological to practical issues. Intensive Care Med 1994; 20:593-601
14. Wright JG, McLeod RS, Mahoney J, et al: Practice guidelines in surgery. Surgery 1996; 119:706-709
15. Schuster DP, Rowley H, Feinstein S, et al: Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76:623-630
16. Cook DJ, Pearl RG, Cook RJ, et al: Incidence of clinically important bleeding in mechanically ventilated patients. J Intensive Care Med 1991; 6: 167-174
17. Ben-Menachem T, Fogel R, Patel RV, et al: Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: A randomized, controlled, single-blind study. Ann Intern Med 1994; 121:568-575
18. Metz CA, Livingston DH, Smith JS, et al: Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: A prospective, multicenter, double-blind, randomized trial. Crit Care Med 1993; 21:1844-1849
19. Chan K, Lai ECS, Tuen H, et al: Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. J Neurosurg 1995; 82:413-417
20. Smythe MA, Zarowitz BJ: Changing perspectives of stress gastritis prophylaxis. Ann Pharmacother 1994; 28: 1073-1085
21. Martin JN: Prophylaxis for stress-related gastric hemorrhage. Ann Intern Med 1995; 122:633
22. Martin LF, Booth FVM, Reines HD, et al: Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg 1992; 215:332-337
23. Tryba M: Stress ulcer prophylaxis-Quo vadis? Intensive Care Med 1994; 20:311-313
24. Navab F, Steingrub J: Stress ulcer: Is routine prophylaxis necessary? Am J Gastroenterol 1995; 90:708-712
25. Cho CH, Koo MWL, Garg GP, et al: Stress-induced gastric ulceration: Its aetiology and clinical implications. Scand J Gastroenterol 1992; 27:257-262
26. McCarthy DM: Sucralfate. N Engl J Med 1991; 325:1017-1025
27. Thomason MH, Payseur ES, Hakenewerth AM, et al: Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. Journal of Trauma, Injury, Infection, and Critical Care 1996; 41:503-508
28. Maier RV, Mitchell D, Gentilello L: Optimal therapy for stress gastritis. Ann Surg 1994; 220:353-363
29. Ben-Menachem T, McCarthy BD, Fogel R, et al: Prophylaxis for stress-related gastrointestinal hemorrhage: A cost-effective analysis. Crit Care Med 1996; 24:338-345